TSLA
Tesla
-- 355.840 NVDA
NVIDIA
-- 138.850 INTC
Intel
-- 23.600 NBIS
NEBIUS
-- 44.490 PLTR
Palantir
-- 119.160 
What to expect from vaccine stocks in 2022
Vaccine stocks ($MRNA, $BNTX, $NVAX, $VALN) generated impressive returns in 2021. However, they dumped in the last couple of weeks. For example $NVAX is down 40% since they approved their vaccine in mid Dec.
I think there will be much more pressure in 2022 since there is higher competition among them, plus more pills get approved, etc.
What are your thoughts for 2022?
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call
Marilyne : PFE is the one vaccine stock that I have shares of. It had a bit of a pull back this last month, but I’m still up about 60% on it and collecting healthy dividends too
walaihuat : I think if you compare MRNA vacccine against protein based technology, and if given a choice earlier with both approved at about the same time, more people will go for protein based (Novavax),at least for me. So I believe the potential for growth is still there provided they don't screw up with delay again.